United States Virtual Clinical Trials Market 2025 | Growth Drivers, Key Players & Investment Opportunities

Market Size and Growth

The Global Virtual Clinical Trials Market reached US$ 8.95 billion in 2024 and is expected to reach US$ 14.42 billion by 2033, growing at a CAGR of 5.5% during the forecast period 2025-2033.

Key Development:

United States: Recent Industry Developments

✅ In September 2025, IQVIA launched its Clinical Trial Financial Suite, an AI-enabled platform designed to streamline financial management across clinical trials. This initiative aims to eliminate inefficiencies caused by siloed systems and fragmented processes.

✅ In August 2025, THL Partners agreed to acquire a majority stake in Headlands Research, a U.S.-based network of clinical trial sites, from KKR in a deal valued at approximately $600 million. This move reflects growing investor interest in clinical trial services.

✅ In July 2025, Carlyle-backed investor Abingworth announced the launch of a $1.5 billion fund to support clinical trials through partnerships with major pharmaceutical firms. The fund aims to finance approximately eight late-stage trials and expects to return $500 million to investors.

Japan: Recent Industry Developments

✅ In July 2025, Verified Clinical Trials (VCT) officially launched operations in Japan through a collaboration with Medical Revolutions Japan (MRJ) and the Japan Association of Contract Institutes for Clinical Pharmacology (JACIC). This initiative addresses the growing challenge of duplicate and professional research subjects in clinical trials.

✅ In March 2025, Japan began the world's first clinical trials for artificial blood, led by Nara Medical University. The artificial blood uses hemoglobin vesicles from expired donations encased in protective shells, eliminating blood type compatibility requirements.

✅ In January 2025, Syneos Health signed an agreement with ACTIVATO to expand its clinical trial capabilities across a broad range of therapeutic areas in Japan. This partnership aims to enhance clinical trial services in the region.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/virtual-clinical-trials-market?sb

Virtual Clinical Trials are studies conducted remotely using digital technologies, wearable devices, telemedicine, and online platforms to monitor participants, collect data, and manage protocols. They enhance patient convenience, expand trial accessibility, reduce costs, and accelerate drug development while maintaining data integrity and regulatory compliance.

Recent Mergers and Acquisitions:

United States: Recent M&A Activity in Virtual Clinical Trials

✅ In January 2025, Suvoda and Greenphire announced a merger to create an integrated technology stack for randomization and patient payments. This strategic move aims to streamline clinical trial operations and enhance efficiency in patient management.

✅ In August 2025, private equity firm THL Partners agreed to acquire a majority stake in Headlands Research, a U.S.-based network of clinical trial sites, from KKR in a deal valued at approximately $600 million. This acquisition reflects growing investor interest in clinical trial services, fueled by increasing pharmaceutical research and aging population healthcare needs.

✅ In July 2025, RockStep Solutions was acquired by Instem, a provider of software solutions for the global life sciences industry. This acquisition aims to expand Instem's capabilities in laboratory data management and enhance its offerings in the clinical trials space.

Japan: Recent M&A Activity in Virtual Clinical Trials

✅ In June 2025, Japanese pharmaceutical company Daiichi Sankyo announced the acquisition of a majority stake in a local digital health startup specializing in virtual clinical trial platforms. This move is part of Daiichi Sankyo's strategy to enhance its digital capabilities and streamline clinical trial processes.

✅ In May 2025, Japanese contract research organization (CRO) CMIC Holdings acquired a minority stake in a U.S.-based company developing AI-powered patient recruitment tools for virtual clinical trials. This acquisition aims to strengthen CMIC's position in the global clinical trials market and leverage advanced technologies for patient recruitment.

✅ In April 2025, Japanese pharmaceutical company Astellas Pharma entered into a partnership agreement with a European digital health company specializing in virtual clinical trial management platforms. This partnership focuses on co-developing and implementing digital solutions to optimize clinical trial operations.

Key Players:

-> IQVIA, ICON plc, Laboratory Corporation of America Holdings, Science 37, Parexel International Corporation, Oracle Corporation, Medidata Solutions, Signant Health, Veristat, LLC, Sanofi and among others.

Growth Forecast Projected:

The Global Virtual Clinical Trials Market is anticipated to rise at a considerable rate during the forecast period, between 2025 and 2033. In 2024, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Virtual Clinical Trials Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=virtual-clinical-trials-market

Key Segments:

➥ By Study Design: Interventional Trials, Observational Trials, Expanded Access Trials
➥ By Indication: Oncology, Neurology, Autoimmune/Inflammation, Cardiovascular Disease, Metabolic/Endocrinology, Infectious Disease, Ophthalmology, Others
➥ By Phase: Phase I, Phase II, Phase III, Phase IV

Regional Analysis for Virtual Clinical Trials Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

Chapter 1: Sets the stage by outlining the report's coverage, summarizing key market segments by region, product type, and application. Presents a snapshot of market sizes, growth potential across segments, and anticipated industry evolution both short and long term.

Chapter 2: Highlights pivotal market insights and uncovers the most significant emerging trends driving change within the industry.

Chapter 3: Offers an in-depth look at the competitive landscape among Virtual Clinical Trials producers, including revenue shares, strategic moves, and recent mergers and acquisitions.

Chapter 4: Presents comprehensive profiles of the market's key players, delving into details such as revenue, profit margins, product portfolios, and company milestones.

Chapters 5 & 6: Analyze Virtual Clinical Trials revenue at both regional and country levels, providing quantitative breakdowns of market sizes, growth opportunities, and development prospects worldwide.

Chapter 7: Focuses on different market segments by type, examining their individual sizes and potential, guiding readers toward high-impact, untapped market areas.

Chapter 8: Explores segmentation by application, evaluating industry growth potential in various downstream markets and pinpointing promising sectors for expansion.

Chapter 9: Provides a thorough review of the industry's supply chain mapping out both upstream and downstream activities.

Chapter 10: Concludes with a summary of the report's key findings and highlights the most critical takeaways for industry stakeholders.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/virtual-clinical-trials-market?sb

FAQ

What is the current size of the Virtual Clinical Trials Market?

A: In 2024, the Virtual Clinical Trials Market was valued at US$ 8.95 billion , reflecting its strong industry presence.

Q2: How large is the Virtual Clinical Trials Market expected to be by 2033?

A: By 2033, industry forecasts suggest the Virtual Clinical Trials Market will grow to around US$ 14.42 billion, demonstrating significant expansion.

Q3: What is the growth rate of the Virtual Clinical Trials Market?

A: The market is projected to expand at a compound annual growth rate (CAGR) of 5.5% during the forecast period from 2025 to 2033.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?sb

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?sb

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.